Sesen Bio Inc
Change company Symbol lookup
Select an option...
SESN Sesen Bio Inc
FSRXW FinServ Acquisition II Equity Warrant Exp 17 Feb 2026 *W EXP 02/17/2026
PTRA Proterra Inc
IH Ihuman Inc
LMT Lockheed Martin Corp
GBRGU Goldenbridge Acquisition Ltd
GBLX GB Sciences Inc
AROC Archrock Inc
AAPL Apple Inc
PCTY Paylocity Holding Corp
Go

Health Care : Biotechnology | Small Cap Blend
Company profile

Sesen Bio, Inc. is a late-stage clinical company providing targeted fusion protein therapeutics (TFPTs) for the treatment of patients with cancer. Its product pipeline includes Vicinium, which is composed of an anti-epithelial cell adhesion molecule (EpCAM) antibody fragment tethered to a truncated form of Pseudomonas exotoxin A for the treatment of BCG-unresponsive non-muscle invasive bladder cancer (NMIBC). The Company's product candidates are based on its TFPT platform and are focused on addressing areas of unmet medical need in cancer. TFPTs are single protein therapeutics composed of targeting domains genetically fused via peptide linkers to cytotoxic protein payloads that are produced through its recombinant one-step, microbial manufacturing process.

Price
Delayed
$1.03
Day's Change
0.0683 (7.10%)
Bid
--
Ask
--
B/A Size
--
Day's High
1.04
Day's Low
0.9936
Volume
(Above Average)

Today's volume of 593,805 shares is on pace to be greater than SESN's 10-day average volume of 4,286,105 shares.

593,805

Display:

Providers:

UpdateCancel
6 providers
November 29, 2021
Sesen Bio Strengthens Medical Team

Sesen Bio (Nasdaq: SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, today announced the strengthening of its medical team with the hiring of Dominika Kowalski as Senior...(BusinessWire)

November 23, 2021
Sesen Bio Director Jane Pritchett Henderson Transitions to CEO Advisor Role

Sesen Bio (Nasdaq: SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, today announced that Jane Pritchett Henderson, previously a member of Sesen Bio's Board of Directors...(BusinessWire)

November 08, 2021
Sesen Bio Reports Third Quarter 2021 Financial Results and Business Update

--Maintained strong balance sheet with $175M in cash and cash equivalents as of September 30, 2021 Sesen Bio (Nasdaq: SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer...(BusinessWire)

November 01, 2021
Sesen Bio Announces Productive CMC Type A Meeting with the FDA

Sesen Bio (Nasdaq: SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, today announced that on October 29, 2021, the Company participated in a productive Type A Meeting with...(BusinessWire)

October 25, 2021
Thinking about buying stock in Advanced Micro Devices, Avadel Pharmaceuticals, Southern Copper, Sesen Bio, or BioNTech?

InvestorsObserver issues critical PriceWatch Alerts for AMD, AVDL, SCCO, SESN, and BNTX. https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.jpg To see how InvestorsObserver's proprietary scoring system rates these stocks, view the...(PR Newswire)

October 20, 2021
Thinking about buying stock in Sesen Bio, FinVolution Group, Valneva SE, Cyclerion Therapeutics, or Icecure Medical?

InvestorsObserver issues critical PriceWatch Alerts for SESN, FINV, VALN, CYCN, and ICCM. https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.jpg To see how InvestorsObserver's proprietary scoring system rates these stocks, view the...(PR Newswire)

October 18, 2021
CLASS ACTION UPDATE for SESN, HYRE and SAM: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

NEW YORK, NY / ACCESSWIRE / October 18, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff...(Accesswire)

SESN Final Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Sesen Bio, Inc. Investors With Losses Exceeding $400K of Class Action and Lead Plaintiff Deadline: October 18, 2021

New York, New York--(Newsfile Corp. - October 18, 2021) - Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Sesen Bio, Inc. ("Sesen Bio" or the "Company") (NASDAQ: SESN) and certain of its...(Newsfile)

SESN DEADLINE TODAY: Hagens Berman Alerts Sesen Bio (SESN) Investors to Today's Lead Plaintiff Deadline in Securities Class Action, Encourages Investors with Significant Losses to Contact Firm's Attorneys Now

SAN FRANCISCO, CA / ACCESSWIRE / October 18, 2021 / Hagens Berman urges Sesen Bio, Inc. (NASDAQ:SESN) investors with losses in excess of $250,000 to submit your losses now. Class Period: Dec. 21, 2020 - Aug. 17, 2021Lead Plaintiff Deadline: Oct. 18...(Accesswire)

SESN Final Deadline Today: Rosen, Global Investor Counsel, Encourages Sesen Bio, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important October 18 Deadline in Securities Class Action - SESN

New York, New York--(Newsfile Corp. - October 18, 2021) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Sesen Bio, Inc. (NASDAQ: SESN) between December 21, 2020 and August 17, 2021, inclusive (the...(Newsfile)

DEADLINE TODAY: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Sesen Bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / October 18, 2021 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Sesen Bio, Inc. ("Sesen Bio" or "the Company") (NASDAQ:SESN) for violations of...(Accesswire)

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Sesen Bio, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 18, 2021 - SESN

New York, New York--(Newsfile Corp. - October 18, 2021) - The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Sesen Bio, Inc. (NASDAQ: SESN) ("Sesen...(Newsfile)

October 17, 2021
SESEN BIO 24 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors with Losses in Excess of $100,000 of Deadline in Class Action Lawsuits Against Sesen Bio, Inc. - SESN

Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until October 18, 2021 to file lead plaintiff applications in a securities class action lawsuit...(PR Newswire)

SESN FINAL DEADLINE: ROSEN, A TOP RANKED LAW FIRM, Encourages Sesen Bio, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Monday Deadline in Securities Class Action - SESN

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Sesen Bio, Inc. (NASDAQ: SESN) between December 21, 2020 and August 17, 2021, inclusive (the "Class Period"), of the important October 18, 2021 lead...(Globe Newswire)

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of SESN, HYRE and APPH

NEW YORK, NY / ACCESSWIRE / October 17, 2021 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the...(Accesswire)

SESN FINAL DEADLINE ALERT: Hagens Berman Encourages Sesen Bio (SESN) Investors with Significant Losses to Contact Firm's Attorneys Before OCT. 18TH LEAD PLAINTIFF DEADLINE in Securities Class Action

San Francisco, California--(Newsfile Corp. - October 17, 2021) -  Hagens Berman urges Sesen Bio, Inc. (NASDAQ: SESN) investors with losses in excess of $250,000 to submit your losses now. Class Period: Dec. 21, 2020 - Aug. 17, 2021Lead Plaintiff...(Newsfile)

Sesen Deadline Alert

New York, New York--(Newsfile Corp. - October 17, 2021) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Sesen Bio, Inc. ("Sesen" or the "Company") (NASDAQ: SESN) and reminds investors of...(Newsfile)

SESEN DEADLINE ALERT: Faruqi & Faruqi LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Sesen To Contact Him Directly To Discuss Their Options

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Sesen Bio, Inc. ("Sesen" or the "Company") (NASDAQ: SESN) and reminds investors of the October 18, 2021 deadline to seek the role of lead...(Globe Newswire)

October 16, 2021
SESEN BIO 48 HOUR DEADLINE ALERT: FORMER LOUISIANA ATTORNEY GENERAL AND KAHN SWICK & FOTI, LLC REMIND INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Deadline in Class Action Lawsuits Against Sesen Bio, Inc. - SESN

NEW ORLEANS, LA / ACCESSWIRE / October 16, 2021 / Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until October 18, 2021 to file lead plaintiff...(Accesswire)

SESN 2-DAY DEADLINE ALERT: Hagens Berman Encourages Sesen Bio (SESN) Investors with Significant Losses to Contact Firm's Attorneys Before OCT. 18TH LEAD PLAINTIFF DEADLINE in Securities Class Action

SAN FRANCISCO, CA / ACCESSWIRE / October 16, 2021 / Hagens Berman urges Sesen Bio, Inc. (NASDAQ:SESN) investors with losses in excess of $250,000 to submit your losses now. Class Period: Dec. 21, 2020 - Aug. 17, 2021 (Accesswire)

Next >

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2021. All rights reserved.